Setting The Standard

Selig (l) said the announcement marked a "proud day, a great day for baseball"

MLB and the MLBPA on Thursday announced a series of significant changes to their joint drug agreement, implementing random, in-season blood testing for HGH beginning this year as well as new protocols to test for heightened testosterone. Every player will now have a baseline testosterone/epitestosterone (T/E) ratio determined each year, allowing for easier and more precise detection of subsequent variances beyond allowable limits. The changes, strongly hinted last fall by MLBPA Exec Dir Michael Weiner, furthers what is already the only HGH testing in major North American pro sports and what baseball calls the strongest drug program in all of sports. MLB Commissioner Bud Selig, speaking following the owners' meetings in Paradise Valley, Ariz ...